Cargando…

Potential SARS-CoV-2 vaccines: Concept, progress, and challenges

Since September 2020, the world has had more than 28 million cases of coronavirus disease 2019 (COVID-19). Many countries are facing a second wave of the COVID-19 outbreak. A pressing need is evident for the development of a potent vaccine to control the SARS-CoV-2. Institutions and companies in man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosseini, Seyede Atefe, Zahedipour, Fatemeh, Mirzaei, Hamed, Kazemi Oskuee, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006194/ https://www.ncbi.nlm.nih.gov/pubmed/33895475 http://dx.doi.org/10.1016/j.intimp.2021.107622

Ejemplares similares

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
por: Zahedipour, Fatemeh, et al.
Publicado: (2022)

Zinc- and Copper-Doped Mesoporous Borate Bioactive Glasses: Promising Additives for Potential Use in Skin Wound Healing Applications
por: Kermani, Farzad, et al.
Publicado: (2023)

The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy
por: Pourhanifeh, Mohammad Hossein, et al.
Publicado: (2019)

Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study
por: Ghafouri, Fatemeh, et al.
Publicado: (2022)

Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
por: Mirzaei, Rasoul, et al.
Publicado: (2020)

The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
por: Mohammadi, Mehrdad, et al.
Publicado: (2021)

Biological Properties, Current Applications and Potential Therapeautic Applications of Brevinin Peptide Superfamily
por: Zohrab, Fatemeh, et al.
Publicado: (2018)

SARS-CoV-2 serology testing: Progress and challenges
por: Shi, Aria C., et al.
Publicado: (2021)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

Challenges and Issues of Anti-SARS-CoV-2 Vaccines
por: Blumental, Sophie, et al.
Publicado: (2021)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
por: Mahboob, Tooba, et al.
Publicado: (2023)

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
por: Kar, Sanchita, et al.
Publicado: (2022)

Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern
por: Salehi, Mohammadreza, et al.
Publicado: (2022)

Brevinin-2R-linked polyethylenimine as a promising hybrid nano-gene-delivery vector
por: Zohrab, Fatemeh, et al.
Publicado: (2019)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Cytokines and microRNAs in SARS-CoV-2: What do we know?
por: Rarani, Fahimeh Zamani, et al.
Publicado: (2022)

The way of SARS-CoV-2 vaccine development: success and challenges
por: Dong, Yetian, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Progress and Prospects on Vaccine Development against SARS-CoV-2
por: Zhang, Jinyong, et al.
Publicado: (2020)

The first detection of SARS-CoV-2 RNA in the wastewater of Tehran, Iran
por: Tanhaei, Mohammad, et al.
Publicado: (2021)

Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses
por: Kim, Kyun-Do, et al.
Publicado: (2020)

Evaluation of SARS-CoV-2 Serum Level in Patients Vaccinated With Sinopharm/BBIBP-CorV With Kidney Transplantation
por: Rahbar, Maryam, et al.
Publicado: (2022)

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
por: Usmani, Salman Sadullah, et al.
Publicado: (2020)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
por: Vashishtha, Vipin M., et al.
Publicado: (2020)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Current vaccine strategies against SARS-CoV-2: Promises and challenges
por: Kurup, Drishya, et al.
Publicado: (2022)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)

Frontier Therapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review
por: SHEIKHSHAHROKH, Amirhossein, et al.
Publicado: (2020)

Wastewater-Based Epidemiology for Community Monitoring of SARS-CoV-2: Progress and Challenges
por: Kumblathan, Teresa, et al.
Publicado: (2021)

Dynamics of host immune responses to SARS-CoV-2
por: Taherkhani, Reza, et al.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2
por: Zhang, Li, et al.
Publicado: (2021)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
por: Li, Tianhong, et al.
Publicado: (2022)

Challenges and developments in universal vaccine design against SARS-CoV-2 variants
por: Zhao, Fangxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9sufjj0bu0ujenol08kqaa642